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TCR-mediated activation of T cell hybridomas induces
programmed cell death by a Fas-dependent pathway. We
now show that costimulation of 2B4 cells, in the absence
or presence of transgenic Bcl-2, with anti-CD3e and
forskolin, an activator of cAMP signaling, resulted in
antagonism of Fas-dependent activation-induced cell
death that was always accompanied by selective down-
regulation of the nuclear levels of NF-kB p65-p50 (RelA-
p50) transcription factor. Forskolin not only inhibited
activation-induced cell death and NF-kB activation, but
also suppressed expression of Fas and Fas ligand (Fas-
L). Furthermore, NF-kB p65 antisense oligonucleotide
down-regulated nuclear levels of NF-kB, inhibited cell
surface expression of Fas-L and apoptosis of 2B4.
Collectively, these finding demonstrate a potential role
of NF-kB in the regulation of activation-induced
apoptosis in T lymphocytes.
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Introduction
Programmed cell death (apoptosis) represents one of
the fundamental regulatory mechanisms in develop-
ment of multicellular organism and in antitumor
immunity. During T cell development apoptosis is
induced in thymocytes which have failed to express a
functional TCR (non-selected or neglected cells) and in
thymocytes which express a high-anity receptor with
potential self-reactivity (negative selection). Both types
of apoptosis eliminate up to 95 – 98% of newly
generated CD4+CD8+ thymocytes at any given time
(Penninger and Mak, 1994). Activation-induced apop-
tosis of mature T cells may play a role for maintaining
peripheral tolerance and for limiting an antigen-specific
T cell response (Ashwell, 1994).
The T cell hybridoma 2B4.11, one of the best models
to study cell death, undergoes apoptosis when it is
stimulated by its cognate antigen, mAbs to CD3e or
Thy-1, dexamethasone (Dex) (Zacharchuk et al., 1990).
These stimulators generate distinct intracellular signals
that activate specific combination of transcription
factors and regulate transcription of genes encoding
proteins which ultimately induce or transduce second-
ary signals leading to cell death (Penninger and Mak,
1994; Krammer et al., 1994). The protooncogene Bcl-2
functions to inhibit several types of apoptotic cell death
including glucocorticoid-induced apoptosis of T cells.
The molecular mechanism by which Bcl-2 inhibits
apoptosis is poorly understood although it must aect
the nature of the intracellular signals induced by
extracellular activating agents (Strasser et al., 1991;
Nunez and Clarke, 1994).
From many identified transcription factors there is a
set of several transcription factor families which are
important for a coordinated regulation of gene
expression during T cell activation, including NF-kB/
Rel, NF-AT, AP-1, Oct, and LEF-1. These transcrip-
tion factors are targets of TCR-mediated signaling
which is dependent from protein kinase C, Ca2+ and
Ras-Raf pathways (Crabtree and Clipstone, 1994;
Chen and Rothenberg, 1994; Baeuerle and Henkel,
1994; Weiss and Littman, 1994). It is likely that some
of the same signaling molecules and transcription
factors that regulate T cell dierentiation and
activation are also important regulators of genes
controlling commitment to apoptosis.
NF-kB is involved in the transcriptional control of
many genes which are expressed in activated
lymphocytes, e.g. IL-2, as well as several genes that
regulate cell death, such as c-myc and tumor
suppresser p53 (Baeuerle and Henkel, 1994; La Rosa
et al., 1994; Wu and Lozano, 1994). NF-kB factors
are found in the nucleus as heterodimers of p50 or
p52 subunits with three dierent members of the Rel
family: RelA (p65), RelB and c-Rel. RelA, RelB and
c-Rel are potent transcription activation subunits
while the p50 and p52 subunits have a DNA binding
domain but no apparent trans-activator domain. NF-
kB p50 or p52 may also form homodimer complexes,
which function as negative regulators of NF-kB-
dependent transcription in vivo (Baeuerle and Hen-
kel, 1994; Baldwin, 1996). NF-kB is present in the
cytoplasm as two major precursor forms either a
complex RelA-p50 with cytoplasmic inhibitors IkB or
a heterodimer RelA-p105. A signal-dependent release
of RelA-p50 from its inhibitors is dependent on
phosphorylation and subsequent proteolytic degrada-
tion of IkB (Thanos and Maniathis, 1995; Baldwin,
1996). Similarly, a second pathway for NF-kB
activation is also the result of phosphorylation and
proteolytic processing of NF-kB p105-p65 precursor
leading to the production and nuclear translocation of
RelA-p50 (Palombella et al., 1994; Thanos and
Maniathis, 1995). The c-Raf kinase was recently
found to function in the kinase cascade leading to
phosphorylation of IkB and activation of NF-kB
resulting in IL-2 production by activated T cells (Li
and Sedivy, 1993; Owaki et al., 1993). By contrast,
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cAMP signaling and protein kinase A (PKA) have
been shown in vivo as negative regulators of c-Raf
function and NF-kB activation (Chen and Rothen-
berg, 1994; Cook and McCormick, 1993; Hafner et
al., 1994; Neumann et al., 1995).
Interaction of Fas Ligand (Fas-L) with Fas antigen
has been implicated in the generation of a death
signaling cascade which is induced by several types of
programmed cell death, including activation-induced
apoptosis of T cells (Watanabe-Fukunaga et al., 1992;
Suda et al., 1993; Nagata and Golstein, 1995; Dhein et
al., 1995; Brunner et al., 1995; Ju et al., 1995; Alderson
et al., 1995; Yang et al., 1995). Forskolin, an activator
of cAMP signaling, has been shown to inhibit
activation-induced apoptosis (Lee et al., 1993) and
NF-kB activation (Chen and Rothenberg, 1994,
Neumann et al., 1995). In present study, we have
investigated a potential role of NF-kB in the concert
with other transcription factors in the regulation of
activation-induced apoptosis of T cells. In addition, we
have also evaluated the interrelationship between
activation and apoptosis by examining the eects of
transgenic Bcl-2 on several transcription factors,
including NF-kB, that are normally up-regulated
upon T cell activation.
Results
Suppression of activation-induced apoptosis in the 2B4 T
cell hybridoma
To evaluate the molecular levels by which TCR-
mediated signaling induces cell death and the extent
by which Bcl-2 may aect the activation-induced
apoptosis, the 2B4 T cell hybridoma was stably
transfected with bcl-2 cDNA in pBMGneo expression
vector. 2B4-Bcl-2 cell line with a relatively high level of
expression of intracellular Bcl-2 was established.
Control 2B4-neo cells were transfected with vector
alone (Ivanov et al., 1995). Similar to previous studies
(Zacharchuk et al., 1990; Hockenbery et al., 1993), we
noted that Dex and anti-CD3 mAb induce apoptosis of
2B4, but overexpression of bcl-2 in 2B4 only
antagonized Dex-induced apoptosis (Figure 1a). Thus,
Bcl-2 does not prevent activation-induced apoptosis in
these cells. As shown previously (Zacharchuk et al.,
1990), costimulation of 2B4 cells by Dex and anti-CD3
resulted in antagonism of apoptosis. However, anti-
CD3-induced apoptosis of 2B4-neo and 2B4-Bcl-2 was
inhibited by forskolin (Figure 1a), an activator of
cAMP signaling, that also blocks IL-2 expression
(Chen and Rothenberg, 1994). Forskolin alone was
poor inducer of death of 2B4 cells (Figure 1a). By
contrast, Dex-induced apoptosis was potentiated by
cAMP signaling (Jondal et al., 1995 and Figure 1a).
DNA fragmentation analysis of 2B4-neo (not shown)
and 2B4-Bcl-2 cells treated with anti-CD3 and/or
forskolin revealed that by 24 h forskolin antagonized
anti-CD3-induced apoptosis as evident by the lower
fraction of cells containing hypodiploid DNA and the
large fraction of cells in the S/G2-M phases of the cell
cycle. Ten mM forskolin alone did not arrest 2B4 cells
in G1 phase (Figure 1b). Forty to fifty mM antioxidant
N-acetylcysteine (NAC) also suppressed activation-
induced apoptosis of 2B4 cells (Figure 1a).
Figure 1 Antagonism of cell death in the 2B4 T cell hybridoma.
(a) 2B4-neo and 2B4-Bcl-2 (56105 cells/ml) were treated with
either 1 mM dexamethasone (Dex), 10 mM forskolin, anti-CD3e
(145-2C11), 50 mM NAC or dierent combinations of these
activators. Percentage of trypan blue positive (dead) cells is
shown. (b) DNA fragmentation analysis by PI staining and flow
cytometry. 2B4-Bcl-2 was cultured with 10 mM forskolin in the
presence or absence of anti-CD3e mAb. The DNA content in the
cells was determined 6 h and 24 h after activation. Markers M1,
M2, M3 and M4 identify apoptotic cells with hypodiploid DNA
content, stage G1, S and G2/M of cell cycle, respectively. The
percentage of apoptotic cells 24 h after treatment is shown at the
right
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Activation-induced apoptosis of 2B4 is Fas dependent
Fas-mediated cell death is dependent upon high cell
density and engagement of Fas by Fas-L (Brunner et
al., 1995; Ju et al., 1995; Alderson et al., 1995; Yang et
al., 1995). Anti-CD3-induced apoptosis of 2B4-neo
(Figure 2a) and 2B4-Bcl-2 was critically dependent
upon cell density with highest levels of apoptosis noted
at a relatively high concentration of cells (1 – 206105/
ml) in culture. In addition, soluble anti-Fas mAb
inhibited anti-CD3-induced apoptosis of 2B4-neo in a
dose-dependent manner as assessed by the levels of
cells with hypodiploid DNA (Figure 2b, left). As a
control, soluble anti-Fas in the absence of anti-CD3
exhibited minimal eect on the cell viability of 2B4-
neo, although a somewhat smaller fraction of cells were
in G2-M phase of the cell cycle (Figure 2b, right).
These data indicate that the majority of activation
induced death of 2B4 is mediated by Fas-dependent
pathway.
Forskolin suppresses expression of Fas and the Fas-L
In view of the potent capacity of forskolin to inhibit
activation-induced apoptosis of T lymphocytes, we
examined whether forskolin might aect the expres-
sion of either Fas or Fas-L by 2B4 cells. Northern
hybridization analysis revealed that anti-CD3 induced
high levels of Fas-L mRNA by both 2B4-neo and
2B4-Bcl-2 6 h after activation, and this induction was
almost completely blocked by forskolin (Figure 3a).
By contrast, anti-CD3 moderately induced Fas
mRNA expression that was most evident after a
24 h culture of 2B4-Bcl-2. When comparing the Fas
mRNA levels to the total amount of RNA, as
determine by probing for GAPDH mRNA, forskolin
appeared to partially inhibit anti-CD3 induced Fas
mRNA (not shown).
Cell surface analysis of Fas-L expression on viable
cells by FACS analysis revealed that forskolin
essentially completely inhibited this protein on 2B4
and 2B4-Bcl-2 cells (Figure 3b, left panel) but only
partially blocked expression of surface Fas (Figure 3c).
This low levels of Fas-L staining using FITC-Fas-Ig
was judged by cold competition by unlabeled Fas-Ig,
but not CD30-Ig (not shown). As an additional
specificity control, forskolin did not inhibit cell surface
expression of other molecules, i.e. Ly6A/E (not
shown). Scattergram analysis demonstrated again that
forskolin inhibited anti-CD3-induced cell death as
assessed by propidium iodide stained cells were
detected in the upper portion of each scattergram
(Figure 3b, right panel). Collectively, these data
indicate that a major target of cAMP-mediated
signaling in the process of cell death is the Fas-L and
Fas expression.
Positive and negative regulation of transcription factors
in activated 2B4 cells by forskolin
To determine whether transcription factor activities are
selectively regulated by forskolin costimulation, we
examined binding activities of several transcription
factors in the beginning (6 h of stimulation with anti-
CD3) and at the final phase of apoptotic commitment
of cells (24 h of stimulation) in the presence or absence
of forskolin (Figure 4a and not shown). As expected,
EMSA experiments showed induction or up-regulation
of several transcription factor activities 6 h after anti-
CD3 treatment, including NF-kB p65-p50 (RelA-p50)
and RelB-p50, which comigrate as the upper band of
NF-kB DNA binding complexes, AP-1 and LEF-1
(Figure 4a). As expected, the CREB/ATF family, a
known target of cAMP signaling (Bridle and Mon-
tminy, 1992), was directly regulated by forskolin. The
intensity of band b2, which probably represents an
unphosphorylated CREB factor, was substantially
decreased whereas bands b3 and b4 (probably,
phosphorylated forms) were strongly up-regulated in
presence of forskolin (Figure 4a). Forskolin and anti-
CD3 costimulation up-regulated the levels of AP-1,
and this may be dye increased heterodimerization of c-
Jun with CREB/ATF by cAMP signaling (Hai and
Curran, 1991). By contrast, forskolin negatively
aected the basal and mAb-induced levels of binding
activity of LEF-1 in both 2B4-neo and 2B4-Bcl-2. For
Oct-1, a slight positive eect of forskolin was detected
for 2B4-neo, but a negative eect for 2B4-Bcl-2 (Figure
4a). These data established that cAMP signaling by
forskolin exerted distinct eects on the nuclear levels of
several transcription factors that are up-regulated upon
T cell activation by anti-CD3.
The strongest inhibitory eect by forskolin and anti-
CD3 costimulation was observed for NF-kB p65-p50
Figure 2 Requirements for Fas/Fas-L for activation-induced
apoptosis of 2B4. (a) Cell density dependency of cell death. 2B4
cells were activated by immobilized anti-CD3e at the indicated cell
density. The percentage of trypan blue positive (dead) cells was
determined 24 h after treatment. (b) Eect of soluble anti-Fas
mAb on apoptosis. DNA fragmentation analysis was performed
in the presence of the indicated concentration of soluble anti-Fas
and immobilized anti-CD3e. DNA content was determined by PI
staining and flow cytometry. Percentage of apoptotic cells (A0) is
shown on the left
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(Figure 4a). By identification of NF-kB complexes
from 2B4 cells in EMSA (Ivanov et al., 1995) based on
inhibition and supershifts after pretreatment of nuclear
extracts with specific antibodies to p65 and RelB, very
little NF-kB p65-p50 complex was detected after
forskolin and anti-CD3 costimulation whereas RelB-
p50 was still easily detected. The lower band of NF-kB
complexes represented p50-p50 homodimer. A quite
similar pattern of transcription factor levels was also
observed 24 h after treatment when the cells were
undergoing maximal levels of activation-induced
apoptosis (not shown). These results correlate en-
hanced levels of NF-kB p65-p50 trans-activator for T
cells undergoing cell death. By contrast, cAMP
signaling led to a significant reduction of cell death
and was accompanied by down-regulation of p65-p50
binding activity. As was previously described (Ivanov
et al., 1995), both untreated and activated 2B4 cells
contained very low levels of NF-AT activity. Costimu-
lation of 2B4 in presence of forskolin down-regulated
these levels (not shown).
NAC and Dex aect transcription factor binding
activities and activation-induced apoptosis 2B4 cells
We examined whether NF-kB p65-p50 was also down-
regulated in other situations in which anti-CD3-
induced apoptosis was suppressed. Costimulation 2B4
cells with anti-CD3 mAb and 50 mM NAC resulted in
suppression of apoptosis (Figure 1a) and down-
regulation of nuclear levels of NF-kB p65-p50 and
LEF-1, while AP-1 activity was not substantially
aected (Figure 4b). Twenty-five mM NAC did not
eectively decrease these levels. In addition, Dex
antagonism of anti-CD3-induced stimulation also
resulted in reduced levels of p65-p50 whereas RelB-
p50 and p50-p50 were minimally aected. Costimula-
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levels of AP-1 and LEF-1 (Figure 4c). In recent
publications (Yang et al., 1995; Williams and
Henkart, 1996), down-regulation of Fas-L levels after
costimulation of T cells by anti-CD3 in the presence of
Dex or NAC was also observed. Hence, down-
regulation of p65-p50 was directly correlated with
suppression of activation-induced apoptosis for all
three cases of the costimulation 2B4 cells in the
presence of apoptotic inhibitors, while changes in the
levels of AP-1 and LEF-1 might be positive or slightly
negative.
Functional role for NF-kB p65-p50 in the regulation of
Fas-L and apoptosis of 2B4 cells
Although the molecular experiments correlated de-
creased levels of NF-kB p65-p50 in each case when
anti-CD3-induced apoptosis was also inhibited, the
data do not demonstrate a direct functional role for
p65-p50 in activation-induced apoptosis. Therefore, the
capacity of sense and antisense NF-kB p65 oligonu-
cleotides on anti-CD3-induced apoptosis of 2B4-Bcl-2
was tested. As an additional non-specific control RelB
sense oligonucleotide was used. Experiments with
labeled oligonucleotides showed a very similar uptake
of all three oligonucleotides into cells (not shown). At a
dose 1 – 10 mg/ml these oligonucleotides were not toxic
and did not aect cell growth. Partial inhibition of 2B4
cell growth was detected at higher concentration of
antisense and sense oligonucleotides (20 mg/ml, not
shown). At a dose of 1 mg/ml (Figure 5b) and 5 mg/ml
(Figure 5a), the antisense p65 oligonucleotide inhibited
the capacity of anti-CD3 to induce cell surface
expression of Fas-L (left panel) and cell death (right
c
Figure 3 Expression of Fas and Fas-L by activated T cell hybridoma. (a) Northern hybridization analysis. 2B4-neo and 2B4-Bcl-2 were
cultured as indicated in the Figure in the presence or absence of forskolin (fors). Total RNA was isolated 6 and 24 h after culture initiation
and probed for Fas, Fas-L and GAPDH mRNA. (b) Cell surface expression of Fas-L. 2B4-Bcl-2 were activated as indicated for 24 h and
stained with Fas-Ig-FITC and PI and analysed by flow cytometry. Percentage of live cells, which was detected by PI exclusion, is shown at
the right. Only live cells, i.e. cells found in the box of each scattergram (right of Figure), were analysed for Fas-L expression to generate the
histograms at the left. MFI represents the medium fluorescence intensity. (c) Cell surface expression of Fas. 2B4 and 2B4-Bcl-2 were stained
by anti-Fas-FITC mAb
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panel). These concentrations of oligonucleotides had
no eect on the cell surface expression of Ly-6A/E
(not shown). An irrelevant oligonucleotide (sense
RelB) did not substantially inhibit anti-CD3-induced
apoptosis or Fas-L expression (not shown). Control
EMSA experiments (Figure 5c) and Western blot
analysis (Figure 5d) also demonstrated that the NF-
kB p65 antisense oligonucleotide specifically inhibited
the up-regulation of the nuclear levels p65-p50 and
p50-p50 after anti-CD3 treatment, while eect of sense
oligonucleotide was minimal. Others have also
observed that antisense p65 oligonucleotide inhibited
levels NF-kB p50-p50 (Kitajima et al., 1992). This
eect may be due to secondary inhibition of p50
transcription, which is under control of NF-kB
(Baeuerle and Henkel, 1994), by down-regulation of
p65-p50 levels.
Discussion
Our data indicate a potential role for NF-kB in the
regulation of T cell apoptosis. This factor appears to
be involved in activation of one or more genes
necessary for Fas-dependent cell death. This conclu-
sion is supported by following observations. (i)
Activation of NF-kB (RelA-p50), Fas/Fas-L expres-
sion and activation-induced apoptosis are inhibited by
cAMP signaling. Furthermore, in the two additional
cases of inhibition of activation-induced T apoptosis
with costimulation in the presence of NAC or Dex, a
down-regulation of NF-kB p65-p50 (present study)
and Fas-L levels (Yang et al., 1995; Williams and
Henkart, 1996) was observed. (ii) A NF-kB antisense
p65 oligonucleotide inhibited nuclear levels of NF-kB,
Fas-L expression, and death of 2B4 cells. (iii) The
putative NF-kB element of Fas-L promoter region
GGAAACTTCC (Takahashi et al., 1994) that diers
from the canonical kB motif (GGGRNNYYCC) only
by one nucleotide, may bind NF-kB p65 subunits in
the concert with other factors (not shown). However,
we have not received data concerning a crucial role
of this site for transcription of Fas-L gene. An
additional study of the transcriptional control of the
Fas-L gene expression is necessary.
We have used the 2B4 T cell hybridoma as a
model cell system. This cell line and its variants have
been widely used to study TCR-mediated activation
of IL-2 production and subsequent cell death
(Zacharchuk et al., 1990; Codias et al., 1990; Ivanov
et al., 1994). Three agents, i.e. forskolin, NAC and
Dex, antagonized anti-CD3-induced apoptosis. Eva-
luation of the nuclear levels of six distinct transcrip-
tion factors that are often induced upon TCR-
mediated signaling showed that NF-kB p65-p50 was
the only transcription factors that was substantially
down-regulated in all cases of costimulation of 2B4.
The nuclear level of LEF-1 was also usually lower,
but in this case the eect was often modest. Thus,
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Figure 4 Eect of forskolin (a), NAC (b) and Dex (c) on
transcription factor levels in 2B4. 2B4-neo and 2B4-Bcl-2 were
activated as indicated. EMSAs were performed with nuclear
proteins 6 h after 2B4 cells activation with 32P-labeled
oligonucleotide probes. Specific DNA-binding complexes are
shown by arrows
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inhibition of apoptosis. Importantly, the presence of
transgenic Bcl-2 in 2B4 cells exerted a minimal eect
on antagonizing activation-induced apoptosis, and
similar molecular changes were noted for 2B4-neo
and 2B4-Bcl-2 cells.
There has been some controversy regarding the role
of Bcl-2 in protecting T cells from activation-induced
apoptosis. Similarly to the observation of others
(Green et al., 1994), overexpression of Bcl-2 by 2B4
did not protect theses cells from anti-CD3-induced cell
death. By contrast, this level of Bcl-2 very eciently
protected 2B4 from Dex-induced apoptosis (Hock-
enbery et al., 1993). The reason for this dierence is
currently not known. Overexpression of Bcl-2 by 2B4
resulted in higher preactivated nuclear levels of several
transcription factors, including NF-kB p65-p50, p50-
p50, AP-1 and NF-AT. Since stimulation by anti-CD3
up-regulates transcription factors, the net eect maybe
potentiation of apoptosis rather than inhibition of cell
death even in the presence of Bcl-2. Alternatively, Bcl-2
may exert its anti-apoptotic activity by selectively
acting on glucocorticoid receptor mediated signaling
and transcription factor activity induced in 2B4 by Dex







































































Figure 5 Eect of NF-kB p65 antisense oligonucleotide on Fas-L expression and apoptosis of 2B4 cells. 2B4-Bcl-2 were activated
with immobilized anti-CD3 mAb, as indicated, for 24 h in the presence of 5 mg/ml (a) or 1 mg/ml (b) of the indicated
oligonucleotide. Cells were stained by Fas-Ig-FITC (left side) and PI and analysed by flow cytometry. The cells in the lower portion
of the scattergram at the right represent viable cells. These cells were analysed for Fas-L expression. NF-kB p65-50 DNA binding
activity (c) and p65 protein levels (d) of oligonucleotide treated cells. EMSA (c) and Western blotting (d) were performed with
nuclear extracts of 2B4-Bcl-2 that were treated as for 24 h as listed above each lane with antisense (AS) or sense (S) NF-kB p65
oligonucleotides
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Similar to results by others (Nagata and Golstein,
1995; Dhein et al., 1995; Brunner et al., 1995; Ju et al.,
1995; Alderson et al., 1995; Yang et al., 1995),
engagement of the TCR by anti-CD3 resulted in
substantial induction of Fas-L expression relatively
early after activation. Fas mRNA and cell surface
protein levels were also induced. Thus, the molecular
determinants necessary for Fas-dependent apoptosis
were expressed by anti-CD3 activated 2B4. We
demonstrated that the majority of anti-CD3-induced
apoptosis by 2B4 is dependent upon Fas/Fas-L
pathway as judged by the relatively high cell density
required for cell death and by capacity of anti-Fas
mAb to inhibit the majority of the cell death. We
cannot rule out that the portion of cell that was
resistant to anti-Fas mAb may occurred by a Fas-
independent pathway.
Past work has demonstrated activation-induced cell
death is inhibited by forskolin (Lee et al., 1993) and
prostaglandin E2 (Goetzl et al., 1995) suggesting that
this biological process was down-regulated upon cAMP
signaling. The molecular basis accounting for this
phenomenon was unknown. Our data indicated that
forskolin inhibited Fas-dependent apoptosis by down-
regulation of cell surface levels of Fas-L and to lesser
extent Fas. Another well characterized target of cAMP
signaling is NF-kB. Forskolin has been shown to act as
a potent suppressor of activation of NF-kB p65-p50
(Chen and Rothenberg, 1994; Neumann, 1995). Our
observation of blockage of apoptosis, Fas-L expression
and NF-kB p65-p50 activation by cAMP signaling and
antisense p65 oligonucleotide has causally associated
NF-kB with induction of Fas-dependent apoptosis.
Additionally, NF-AT activity is also suppressed by
cAMP-mediated signaling. Although we have not
established the key target gene(s) which are regulated
by NF-kB and/or NF-AT for Fas-dependent cell death,
one attractive candidate is the expression of the Fas-L
gene itself. Analysis of the 5' regulatory region of the
Fas-L gene has revealed a relatively restricted set of
binding sites for known transcription factors, including
NF-kB (Takahashi et al., 1994). Our analysis of the
capacity of this element to bind to NF-kB demon-
strated relatively weak binding of RelA subunit when
compared to NF-kB binding to HIV promoter (not
shown). Furthermore, slight but detectable levels of
NF-ATp binding by the same Fas-L site was also
observed in preliminary experiments. These data
suggest that combinatorial binding both NF-kB and
NF-AT subunits to this region may be functionally
relevant. Possible interactions between NF-kB and NF-
AT transcription factor families (both families belong
to the Rel superfamily) in the regulation of transcrip-
tion were previously described (McCarey et al., 1992;
Casolaro et al., 1995).
Two other transcription factors have been implicated
in the regulation of activation-induced apoptosis, c-
Myc (Shi et al., 1992) and orphan receptor Nur-77 (Liu
et al., 1994; Woronicz et al., 1994). A precise role for
Nur-77 in transcriptional regulation has not yet
established. However, NF-kB has been shown to
control transcription of c-myc (La Rosa et al., 1994),
indicating a possible interrelationship between these
two factors in the regulation of apoptosis. It is also
interesting to note that TNF receptor associated
protein TRADD not only signals cell death but also
activates NF-kB (Hsu et al., 1995). In this case the
signals leading to cell death and NF-kB activation were
shown to be distinct. By contrast to present study, for
the TNF-dependent systems activation of NF-kB
prevented or down-regulated apoptosis (Wang et al.,
1996; Beg and Baltimore, 1996; Liu et al., 1996; Van
Antwerp et al., 1996). These very interesting data, as
well as our former data concerning a role of NF-kB for
T cell development (Ivanov et al., 1993), demonstrated
a dual (positive or negative) role of NF-kB in the
apoptotic regulation of dierent cell systems. Although
results of the present study have implicated NF-kB in
Fas-mediated apoptosis, it does not preclude a broader
role for this transcription factor in regulation of
programmed cell death. In this respect, very promising
observation was recently reported concerning pheno-
type of IkBa knockout mice (Beg et al., 1995). These
mice are characterized by constitutive NF-kB (RelA-
p50) activation, thymic atrophy and reduction of
proportion of DP thymocytes 6 days after birth that
indicated, probably, a role of RelA-p50 in thymocyte
apoptosis. In other hand, recently described NF-ATp
knockout mice (Hodge et al., 1996) were characterized
by very strong reduction of induced Fas-L levels in T
cells that further indicated a role of NF-AT for the
regulation of Fas-L expression.
Materials and methods
Cells
The 2B4 T cell hybridoma (Zacharchuk et al., 1990) and its
transfected variants were cultured in RPMI 1640 medium
supplemented with 5% fetal calf serum, 50 mM 2-
mercaptoethanol and antibiotics. 2B4 cells were trans-
fected with bcl-2 cDNA in the pBMGneo expression vector
(Karasuyama and Melchers, 1988; Deng and Podack, 1993)
by electroporation and selected for G-418 resistance. A cell
line with high-level expression of bcl-2 mRNA was
established on the basis of Northern blot analysis (2B4-
Bcl-2). Control cells were 2B4 transfected with the
unmodified vector pBMGneo (2B4-neo) (Ivanov et al.,
1995)
Antibodies
The mAb 145-2C11 to CD3e (Leo et al., 1987) has been
described previously. The mAb to mouse Fas (Jo2) and the
polyclonal Ab to mouse RelA (p65) were purchased from
PharMingen (San Diego, CA) and Santa Cruz Biotechnol-
ogy (Santa Cruz, CA), respectively.
Fas-Ig construction
Mouse Fas-Ig cDNA was constructed by fusing mouse Fas
cDNA, truncated at the extracellular domain next to the
transmembrane segment (fragment A) with the g chain of
mouse IgG1 (fragment B) starting at the hinge region.
These cDNAs were synthesized by RT – PCR, simulta-
neously introducing XhoI cloning sites and mutating the
three cysteines of the IgG1 hinge to serines. For
construction of fragment A, RNA was isolated from
mouse thymocytes, transcribed into cDNA, and PCR was
performed using the primers to produce the extracellular
domain of murine Fas with 5' XhoI end and 3' mouse IgG1
linker (primer 1 – 5'-ATC CCT GGG CAC GCG ATT
TCT GGG ACT TTG TTT CCT-3' and primer 2 – 5'-TTT
CTC GAG ATT TTC ACT CCA GAC ATT GTC CTT
C-3'). Fragment B was amplified by RT – PCR using RNA
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isolated from a mIgG1 secreted hybridoma (primer 3 – 5'-
CCC AGA AAT CGC GTG CCC AGG TCT GGT TCT
AAG-3' and primer 4 – 5'-AGC TTT CTC GAG AAG GA-
C ACT GGG ATC ATT TAC CAG G-3') so fragment B
contained a 5' ends complementary to the 3' ends of the
fragment A and had 3' XhoI ends. Fragments A and B
were fused by PCR using primers 1 and 4 to produce Fas-
Ig cDNA which was cloned into plasmid PCR II
(Invitrogen, San Diego, CA).
The Fas-Ig cDNA was subcloned into XhoI site of
pBMGneo (Karasuyama and Melchers, 1988) and trans-
fected into NIH3T3 cells. Fas-Ig fused protein was purified
from supernatants of transfected cells using the Protein A
MAPS System (‘Bio-Rad’, Hercules, CA). The Fas-Ig was
conjugated with FITC Isomer I on Celite (Calbiochem, La
Jolla, CA).
T cell activation and flow cytometry
2B4 cells were activated with anti-CD3e in 24-well flat-
bottom plates that were coated with purified anti-CD3
(10 mg/ml) for 3 h prior to initiation of culture. Forskolin
(10 mM), NAC (20 – 50 mM) Dex (1 mM) (Sigma, St Louis,
MO) were added as indicated.
2B4 was directly stained with an excess of FITC-Fas,
FITC-anti-Ly-6A/E, FITC-Fas-Ig, FITC-anti-CD3. Cells
were pretreated with 2.4G2 mAb to block FcR. Flow
cytometric analysis was performed on FACScan flow
cytometer (Becton Dickinson, Mountain View, CA).
Antisense oligonucleotide treatment
The sense and antisense phosphorothioate analogs of the
oligonucleotides to the 5' end of NF-kB p65 mRNA,
including the ATG initiation codon, were synthesized [NF-
kB p65-sense oligonucleotide CTG ACC ATG GAC -
GAT CTG TTT CCC, NF-kB p65-antisense oligonucleo-
tide GGG AAA CAG ATC GTC CAT GGT CAG (Nolan
et al., 1992; Kitajima et al., 1992)]. As non-specific control,
RelB sense oligonucleotide was used [CGG GCC ATG AA-
G AGT CGC CGC GCT (Ryseck et al., 1992)]. Oligonu-
cleotides were used at the final concentration in the range
of 1 – 5 mg/ml of culture media. Cells were first preincu-
bated for 4 h with oligonucleotides following by stimula-
tion with anti-CD3 for additional 16 h.
DNA fragmentation analysis
After fixation with 70% ethanol in PBS, cells were pelleted
and resuspended in 0.5 ml of PBS containing propidium
iodide (40 mg/ml) and DNase-free RNase A (10 mg/ml).
Cells were incubated at 378C for 30 min and then analysed
on a FACScan (Becton Dickinson, CA).
Oligonucleotides and electrophoretic mobility shift assay
(EMSA)
The following double-stranded oligonucleotides were used in
this study as specific probes for transcription factors (only
one strand of a double-stranded oligonucleotide is shown,
binding sites of transcription factors are underlined):
agctTGGGGACTTTCCAGCCG for NF-kB; agctT
GATGAGTCAGCCG for AP-1; agctCCATGACGTC-
ATGG for CREB; AAAGAGGAAAATTTGTTTCATACAGAA
for NF-AT; GAAAATATGTGTAATATGTAAAACATTTTG
for OCT; AAAAAAGAACAAAGGGCCTAG-ATT for
LEF-1; GTCTGAAACATTTTTCTGATTGGTTAAAAGTT-
GAGTGCT for NF-Y.
These oligonucleotides were end-labeled with [g-32P]ATP
using T4 polynucleotide kinase. Nuclear extracts were
prepared from 5 – 156106 T cells. Binding reactions were
carried out by incubating the end-labeled DNA
(50 000 c.p.m.) with 5 mg of nuclear proteins and 2 mg of
poly(dI-dC) as previously described (Ivanov et al., 1993).
Northern hybridization analysis
Cytoplasmic cell extracts were used for isolation and
purification of total RNA by SDS-phenol method. Total
RNA was separated on formaldehyde/MOPS agarose gel
and blotted on Hybond N membranes (Amersham,
Arlington Heights, IL) which were hybridized with 32P-
labeled DNA probes for Fas (Watanabe-Fukunaga et al.,
1992), Fas-L (Suda et al., 1993), and GAPDH.
Western blot analysis
Nuclear extracts were resolved on a 10% SDS – PAGE,
transferred to nitrocellulose and processed by standard
manual. The polyclonal Ab against RelA wasa used at
dilution 1 : 1000. The secondary Ab was goat anti-rabbit
IgG conjugated to horseradish peroxidase (dilution
1 : 4000). Signals were detected using the ECL system
(Amersham, Arlington Heights, IL).
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